<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.</h1>
  <ul>
<li>Caution – CE marked since 2019.</li>
<li>FDA approved in August 2025 as prescription-only device.</li>
<li>Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021.</li>
<li>Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019.</li>
<li>Mont-Saint-Guibert, Belgium – September 15, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) and Nyxoah, Inc.</li>
<li>8,700,183, 9,415,215, and 9,415,216.</li>
<li>Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31</li>
</ul>
<p><a href="https://finance.yahoo.com/news/nyxoah-files-patent-infringement-lawsuit-201000143.html">Source</a> · 2025-09-15T20:10:00+00:00</p>
</body>
</html>